136 related articles for article (PubMed ID: 26766304)
1. Rituximab in the Treatment of Refractory Noninfectious Scleritis.
Cao JH; Oray M; Cocho L; Foster CS
Am J Ophthalmol; 2016 Apr; 164():22-8. PubMed ID: 26766304
[TBL] [Abstract][Full Text] [Related]
2. Rituximab in the treatment of refractory scleritis in patients with granulomatosis with polyangiitis (Wegener's).
Recillas-Gispert C; Serna-Ojeda JC; Flores-Suárez LF
Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2279-84. PubMed ID: 26507398
[TBL] [Abstract][Full Text] [Related]
3. Rituximab Induction and Maintenance Treatment in Patients with Scleritis and Granulomatosis with Polyangiitis (Wegener's).
You C; Ma L; Lasave AF; Foster CS
Ocul Immunol Inflamm; 2018; 26(8):1166-1173. PubMed ID: 28628344
[TBL] [Abstract][Full Text] [Related]
4. Rituximab therapy for refractory scleritis: results of a phase I/II dose-ranging, randomized, clinical trial.
Suhler EB; Lim LL; Beardsley RM; Giles TR; Pasadhika S; Lee ST; de Saint Sardos A; Butler NJ; Smith JR; Rosenbaum JT
Ophthalmology; 2014 Oct; 121(10):1885-91. PubMed ID: 24953794
[TBL] [Abstract][Full Text] [Related]
5. Cyclophosphamide or Rituximab Treatment of Scleritis and Uveitis for Patients with Granulomatosis with Polyangiitis.
Ahmed A; Foster CS
Ophthalmic Res; 2019; 61(1):44-50. PubMed ID: 29635229
[TBL] [Abstract][Full Text] [Related]
6. Rituximab therapy for refractory idiopathic scleritis.
Bogdanic-Werner K; Fernandez-Sanz G; Alejandre Alba N; Ferrer Soldevila P; Romero-Bueno FI; Sanchez-Pernaute O
Ocul Immunol Inflamm; 2013 Aug; 21(4):329-32. PubMed ID: 23662782
[TBL] [Abstract][Full Text] [Related]
7. Methotrexate for the treatment of noninfectious scleritis.
Sands DS; Chan SCY; Gottlieb CC
Can J Ophthalmol; 2018 Aug; 53(4):349-353. PubMed ID: 30119788
[TBL] [Abstract][Full Text] [Related]
8. Management of necrotizing scleritis after pterygium surgery with rituximab.
Fidelix TS; Vieira LA; Trevisani VF
Arq Bras Oftalmol; 2016; 79(5):339-341. PubMed ID: 27982218
[TBL] [Abstract][Full Text] [Related]
9. Analysis of a novel protocol of pulsed intravenous cyclophosphamide for recalcitrant or severe ocular inflammatory disease.
Suelves AM; Arcinue CA; González-Martín JM; Kruh JN; Foster CS
Ophthalmology; 2013 Jun; 120(6):1201-9. PubMed ID: 23601800
[TBL] [Abstract][Full Text] [Related]
10. Infliximab for the treatment of refractory scleritis.
Doctor P; Sultan A; Syed S; Christen W; Bhat P; Foster CS
Br J Ophthalmol; 2010 May; 94(5):579-83. PubMed ID: 19955205
[TBL] [Abstract][Full Text] [Related]
11. LONG-TERM OUTCOMES OF RITUXIMAB THERAPY IN PATIENTS WITH NONINFECTIOUS POSTERIOR UVEITIS REFRACTORY TO CONVENTIONAL IMMUNOSUPPRESSIVE THERAPY.
Lasave AF; You C; Ma L; Abusamra K; Lamba N; Valdes Navarro M; Meese H; Foster CS
Retina; 2018 Feb; 38(2):395-402. PubMed ID: 28225369
[TBL] [Abstract][Full Text] [Related]
12. Visual outcome, treatment results, and prognostic factors in patients with scleritis.
Wieringa WG; Wieringa JE; ten Dam-van Loon NH; Los LI
Ophthalmology; 2013 Feb; 120(2):379-86. PubMed ID: 23177360
[TBL] [Abstract][Full Text] [Related]
13. Mycophenolate mofetil after methotrexate failure or intolerance in the treatment of scleritis and uveitis.
Sobrin L; Christen W; Foster CS
Ophthalmology; 2008 Aug; 115(8):1416-21, 1421.e1. PubMed ID: 18221998
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis.
Murphy CC; Ayliffe WH; Booth A; Makanjuola D; Andrews PA; Jayne D
Ophthalmology; 2004 Feb; 111(2):352-6. PubMed ID: 15019389
[TBL] [Abstract][Full Text] [Related]
15. Outcome of tocilizumab treatment in refractory ocular inflammatory diseases.
Silpa-Archa S; Oray M; Preble JM; Foster CS
Acta Ophthalmol; 2016 Sep; 94(6):e400-6. PubMed ID: 27010181
[TBL] [Abstract][Full Text] [Related]
16. Retrospective review of methotrexate therapy in the treatment of chronic, noninfectious, nonnecrotizing scleritis.
Jachens AW; Chu DS
Am J Ophthalmol; 2008 Mar; 145(3):487-492. PubMed ID: 18282493
[TBL] [Abstract][Full Text] [Related]
17. Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis.
Taylor SR; Salama AD; Joshi L; Pusey CD; Lightman SL
Arthritis Rheum; 2009 May; 60(5):1540-7. PubMed ID: 19404964
[TBL] [Abstract][Full Text] [Related]
18. Scleritis therapy.
Sainz de la Maza M; Molina N; Gonzalez-Gonzalez LA; Doctor PP; Tauber J; Foster CS
Ophthalmology; 2012 Jan; 119(1):51-8. PubMed ID: 22015381
[TBL] [Abstract][Full Text] [Related]
19. New Potential Weapons for Refractory Scleritis in the Era of Targeted Therapy.
Fabiani C; Sota J; Sainz-de-la-Maza M; Pelegrín L; Emmi G; Lopalco G; Iannone F; Vannozzi L; Guerriero S; Gelmi MC; Rigante D; Tosi GM; Hernández-Rodríguez J; Cantarini L
Mediators Inflamm; 2020; 2020():8294560. PubMed ID: 32410867
[TBL] [Abstract][Full Text] [Related]
20. Gevokizumab in the Treatment of Autoimmune Non-necrotizing Anterior Scleritis: Results of a Phase I/II Clinical Trial.
Knickelbein JE; Tucker WR; Bhatt N; Armbrust K; Valent D; Obiyor D; Nussenblatt RB; Sen HN
Am J Ophthalmol; 2016 Dec; 172():104-110. PubMed ID: 27663070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
